Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2010
03/05/2010CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin
03/04/2010WO2010025400A2 Cross-reactive and bispecific anti-el 17a/f antibodies
03/04/2010WO2010025369A2 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
03/04/2010WO2010025321A2 Method for treating multiple sclerosis patients with anti-il2r antibodies
03/04/2010WO2010024776A1 Anln protein as an endocrine treatment predictive factor
03/04/2010WO2010024293A1 Set of anti-vasohibin monoclonal antibodies
03/04/2010WO2010024271A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard
03/04/2010WO2010023482A2 Therapeutic antibody
03/04/2010WO2010023382A1 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
03/04/2010WO2010022924A1 Antibodies against human epo receptor
03/04/2010WO2010022740A2 Hiv-1 envelope polypeptides for hiv vaccine
03/04/2010WO2010022738A1 Method for cloning avian-derived antibodies
03/04/2010WO2010022737A1 Anti-cd5 antibodies
03/04/2010WO2010022736A2 Recombinant anti-epidermal growth factor receptor antibody compositions
03/04/2010WO2010022734A1 Treatment of thrombocytopenia
03/04/2010WO2010022463A1 Prevention, treatment and diagnosis of p.gingivalis infection
03/04/2010WO2010006296A3 New avian bornavirus
03/04/2010WO2010000849A3 Conserved secreted proteins from protozoan parasites
03/04/2010WO2009156179A8 Her3 as a determinant for the prognosis of melanoma
03/04/2010WO2009149189A3 Dual variable domain immunoglobulins and uses thereof
03/04/2010WO2009149185A3 Dual variable domain immunoglobulins and uses thereof
03/04/2010WO2009134428A3 Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage
03/04/2010WO2009046294A3 Treatment of proliferative disorders using antibodies to psma
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010WO2008151088A9 Immunoglobulin constant region fc receptor binding agents
03/04/2010US20100058489 Nucleic Acid Encoding A Brain Derived Tau Kinase Polypeptide and Methods of Use Thereof
03/04/2010US20100058488 Protein formulations comprising s1-5
03/04/2010US20100056764 Antibodies against human NKG2D and uses thereof
03/04/2010US20100056763 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method
03/04/2010US20100056762 Specific binding proteins and uses thereof
03/04/2010US20100056761 Antibodies against erbb3 and uses thereof
03/04/2010US20100056760 Sialoadhesin factor-2 antibodies
03/04/2010US20100056759 Methods and Compositions for Efficient Removal of Protein A from Binding Molecule Preparations
03/04/2010US20100056758 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
03/04/2010US20100056757 Clarification of transgenic milk using depth filtration
03/04/2010US20100056611 MN/CA9 Splice Variants
03/04/2010US20100056439 Ligands that have binding specificity for egfr and/or vegf and methods of use therefor
03/04/2010US20100056428 Modified proteins
03/04/2010US20100056386 Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
03/04/2010US20100055794 Selection of Cells Expressing Heteromeric Polypeptides
03/04/2010US20100055778 Mammalian zcytor 11
03/04/2010US20100055715 Nucleic and amino acid sequences of prokaryotic ubiquitin-like protein and methods of use thereof
03/04/2010US20100055714 IKB kinase, subunits thereof, and methods of using same
03/04/2010US20100055675 Method for detecting measles virus, membrane assay test device, and membrane assay test kit
03/04/2010US20100055506 Newly Discovered Bacterium in the Family Acetobacteraceae
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055126 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
03/04/2010US20100055123 Vaccine against burkholderia infections
03/04/2010US20100055120 Prostate stem cell antigen (psca) variants and subsequences thereof
03/04/2010US20100055115 Compositions and methods for stem cell delivery
03/04/2010US20100055114 Use of integrin alpha 10 binding antibody to modulate extracellular matrix (cartilage) turnover
03/04/2010US20100055112 Enterococcus faecalis and/or Enterococcus faecium antigen
03/04/2010US20100055109 Post-translationally modified neurotrophins
03/04/2010US20100055108 Drug for treating gastric cancer
03/04/2010US20100055105 Novel Isolated And Purified Strains Of Chikungunya Virus And Polynucleotides And Polypetide Sequences, Diagnostic And Immunogenical Uses Thereof
03/04/2010US20100055103 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010US20100055101 Cytokine receptor zcytor17 multimers
03/04/2010US20100055097 Stable lyophilized pharmaceutical formulation of igg antibodies
03/04/2010US20100055093 Pan-cell surface receptor-specific therapeutics
03/04/2010US20100055092 Preventive or Remedy for Inflammatory Disease
03/04/2010US20100055091 Novel GL-50 Molecules and Uses Therefor
03/04/2010US20100055085 Hydrolases, nucleic acids encoding them and methods for making and using them
03/04/2010US20100055034 Human Anti-Folate Receptor Alpha Antibodies and Antibody Fragments for the Radioimmunotherapy of Ovarian Carcinoma
03/04/2010US20100055033 Antibody compositions and methods for treatment of neoplastic disease
03/04/2010CA2735279A1 Anti-cd5 antibodies
03/04/2010CA2735278A1 Hiv-1 envelope polypeptides for hiv vaccine
03/04/2010CA2735230A1 Hydrolases, nucleic acids encoding them and methods for making and using them
03/04/2010CA2735171A1 Prevention, treatment and diagnosis of p.gingivalis infection
03/04/2010CA2735169A1 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
03/04/2010CA2735155A1 Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases
03/04/2010CA2735020A1 Method for cloning avian-derived antibodies
03/04/2010CA2734779A1 Treatment of thrombocytopenia
03/04/2010CA2734174A1 Anln protein as an endocrine treatment predictive factor
03/04/2010CA2733140A1 Antibodies against human epo receptor
03/04/2010CA2732856A1 Recombinant anti-epidermal growth factor receptor antibody compositions
03/04/2010CA2732642A1 Cross-reactive and bispecific anti-il-17a/f antibodies
03/04/2010CA2730909A1 Method for treating multiple sclerosis patients with anti-il2r antibodies
03/03/2010EP2159577A1 Novel marker for arteriosclerotic disease
03/03/2010EP2159281A1 Novel slc17-type transporter protein in mammal and use thereof
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP2158917A1 P.ariasi polypeptides, P.perniciosus polypeptides and methods of use
03/03/2010EP2158327A2 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
03/03/2010EP2158318A2 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
03/03/2010EP2158315A2 Methods of modifying antibodies, and modified antibodies with improved functional properties
03/03/2010EP2158222A1 Milk derived antigen specific antibodies, methods of preparation and uses thereof
03/03/2010EP2158221A2 Covalent diabodies and uses thereof
03/03/2010EP2158220A1 Display of binding agents
03/03/2010EP2158219A2 Polypeptides, antibody variable domains & antagonists
03/03/2010EP2158218A2 Polypeptides, antibody variable domains & antagonists
03/03/2010EP2158217A1 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
03/03/2010EP1743648B1 Method for treating inflammation
03/03/2010EP1651266B1 Administration of anti-tnf-alpha f(ab')2 antibody fragments
03/03/2010EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics
03/03/2010EP1419179B1 Antigen binding domains from fish
03/03/2010EP1286682B1 Methods and compositions for inhibiting immunoglobulin-mediated-reperfusion injury
03/03/2010CN101663323A Compositions and methods for the treatment of infections and tumors
03/03/2010CN101663322A Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
03/03/2010CN101663321A Antagonistic human light-specific human monoclonal antibodies
03/03/2010CN101663320A engineered anti-il-23p19 antibodies
03/03/2010CN101663319A Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathologica
1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 1494